NCT05185856

Brief Summary

Eccentric muscle work is defined as lengthening of a muscle while applying force. It was shown that with eccentric work, muscles are able to perform four times as much power compared to usual concentric work, which results in huge training gain with a highly decreased oxygen demand and thus lower cardiovascular load. Pulmonary hypertension (PH) is a chronic condition associated with significant reduced exercise capacity and increased morbidity and mortality, resulting in reduced quality of life. Physical training has been shown to be beneficial in PH, even in severely limited patients. However, due to cardiopulmonary constraints in PH, training intensities may be very low, so that many patients are physically almost unable to perform exercise on a high enough level to maintain muscle mass. A low body muscle not only feeds the vicious cycle of decreasing exercise capacity, but also has many deleterious metabolic and immunological consequences which further increase disability and decrease quality of life in PH. Thus, eccentric training, which allows to gain muscle mass with a low stress to the cardiopulmonary unit may to be highly beneficial for patients with PH and allied cardiopulmonary disease, such as chronic obstructive pulmonary disease (COPD) and heart failure. Therefore, the aim of the study is to compare differences in oxygen uptake (peak VO2 \[l/min\]) and other physiological measures during similar cardiopulmonary exercise test protocols of eccentric- vs. concentric cycling in PH- patients and comparators with or without other cardiopulmonary diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
1.8 years until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

January 23, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

December 6, 2021

Last Update Submit

January 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oxygen uptake (peak VO2 [l/min])

    Difference in oxygen uptake (peak VO2 \[l/min\]) of eccentric vs. concentric cycling exercise.

    1 Day

Secondary Outcomes (15)

  • Respiratory exchange ratio (RER)

    1 day

  • Breathing equivalent for carbon dioxide

    1 day

  • Pulmonary end tidal carbon dioxide (PET CO2)

    1 day

  • Arterial oxygen saturation (SpO2)

    1 day

  • Borg Scale for dyspnea

    1 day

  • +10 more secondary outcomes

Study Arms (2)

Start with: Concentric (normal) cycling

SHAM COMPARATOR

Patients that are allocated to this arm will start with normal cycling

Procedure: 15 minutes eccentric cyclingProcedure: 15 minutes concentric (normal) cycling

Start with: Eccentric cycling

EXPERIMENTAL

Patients that are allocated to this arm will start with eccentric cycling

Procedure: 15 minutes eccentric cyclingProcedure: 15 minutes concentric (normal) cycling

Interventions

The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.

Start with: Concentric (normal) cyclingStart with: Eccentric cycling

The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.

Start with: Concentric (normal) cyclingStart with: Eccentric cycling

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In a stable condition on the same disease specific medication \>4 weeks.
  • Signed informed consent.
  • Patients with chronic obstructive pulmonary (COPD) with a FEV1/FVC-ratio \> 0.7

You may not qualify if:

  • Severe daytime hypoxemia (pO2 ≤7.3 kPa or \<55 mmHg).
  • Other clinically significant concomitant disease states (e.g., renal, hepatic dysfunction, etc.).
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorder, dementia or confusional state of the subject, neurological or orthopedic problems with inability to ride a bicycle.
  • Woman with known pregnancy (Women with known pregnancy will not be allowed into the study. It will however not be searched for early unknown pregnancy in woman of child-bearing potential, as cycling is not contraindicated in early unknown pregnancy stage and we thus do not plan routine pregnancy tests before study entrance in women of childbearing potential).
  • Enrolment into another clinical trial with active treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Respiratory Clinic, University Hospital of Zurich

Zurich, Canton of Zurich, 8091, Switzerland

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2021

First Posted

January 11, 2022

Study Start

November 15, 2023

Primary Completion

May 31, 2024

Study Completion

May 31, 2024

Last Updated

January 23, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations